| |
| |
|
| Insider
Information: |
Ketchum Steven B |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
742,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$495,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
742,979 |
|
|
| Total
Value |
$495,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2015-07-24 |
84,259 |
2010-06-30 |
0 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
|
2024-01-31 |
658,720 |
2015-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-08 |
4 |
S |
$5.08 |
$53,364 |
D/D |
(10,503) |
73,961 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-08 |
4 |
OE |
$2.09 |
$21,951 |
D/D |
10,503 |
84,464 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-02-26 |
4 |
D |
$6.74 |
$77,395 |
D/D |
(11,483) |
437,246 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-07-31 |
4 |
D |
$1.19 |
$13,998 |
D/D |
(11,763) |
600,231 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,053 |
72,921 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,733 |
491,208 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-01-31 |
4 |
D |
$1.86 |
$25,493 |
D/D |
(13,706) |
564,882 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2010-07-30 |
4 |
D |
$0.49 |
$6,932 |
D/D |
(14,293) |
365,211 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-02-21 |
4 |
D |
$1.80 |
$26,136 |
D/D |
(14,520) |
579,496 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2024-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,566 |
604,907 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,333 |
502,420 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,333 |
595,829 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-12-30 |
4 |
D |
$1.21 |
$19,797 |
D/D |
(16,361) |
544,021 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
D/D |
16,656 |
86,378 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-12-31 |
4 |
AS |
$13.51 |
$230,212 |
D/D |
(17,041) |
341,297 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-12-31 |
4 |
OE |
$1.40 |
$40,985 |
D/D |
17,041 |
358,338 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-10-31 |
4 |
AS |
$20.72 |
$353,454 |
D/D |
(17,042) |
341,297 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-10-31 |
4 |
OE |
$1.40 |
$40,988 |
D/D |
17,042 |
358,339 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
AS |
$17.79 |
$303,174 |
D/D |
(17,042) |
341,297 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
OE |
$1.40 |
$40,988 |
D/D |
17,042 |
358,339 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-07 |
4 |
S |
$5.03 |
$98,295 |
D/D |
(19,551) |
73,961 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-07 |
4 |
OE |
$2.09 |
$40,862 |
D/D |
19,551 |
93,512 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-01-29 |
4 |
D |
$7.50 |
$161,513 |
D/D |
(21,535) |
408,366 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,446 |
445,601 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-12-29 |
4 |
A |
$0.87 |
$20,467 |
D/D |
23,525 |
590,341 |
0 |
- |
|
132 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
